利复星序贯疗法治疗急性下呼吸道细菌感染的研讨  

Study on the sequential therapy of levofloxacin in treatment of acute lower respiratory tract bacterial infections

作　　者：韩钢[1] 

机构地区：[1]天津市滨江医院老年病专科,300022

出　　处：《天津医科大学学报》2001年第1期97-99,共3页Journal of Tianjin Medical University

摘　　要：目的 :评价利复星序贯疗法治疗急性下呼吸道细菌性感染的疗效和安全性。方法 :对102例急性下呼吸道细菌感染患者 ,采用利复星400mg/d ,5～7d静脉滴注 ,继之以利复星400mg/d,4～7d口服。结果 :痊愈30例(29.4% ) ,显效64例 (62.7% ) ,有效率92.1 % ,细菌清除率88.9% ,总疗程9～14d(平均11.8d) ,药物副作用发生较少 (发生率3.92 % )。结论 :利复星序贯疗法治疗急性下呼吸道常见细菌性感染有效、安全。Objective:To evaluate the efficacy and safety of Levofloxacin in treatment of acute lower respiratory tract bacterial infection (ALRTBI) by sequential therapy. Methods:One hundred and two patients with ALRTBI were treated with Levofloxacin iv drip in a regimen of 400mg/d for 5～7d then with oral Levofloxacin in dose of 400mg/d for 4～7d in sequence. Results: An effective rate of 92.1% and a bacterial eradication rate of 88.9% were obtained with a tolerable side effect of 3.92%. Conclusion: Levofloxacin in sequential therapy is an effective and safe agent for treatment of ALRTBI.

关 键 词：利复星 细菌感染 下呼吸道感染 治疗 

分 类 号：R563.105[医药卫生—呼吸系统]